Symbols / ICVX
ICVX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Icosavax shares positive early results for VLP vaccine candidate against RSV - drugdiscoverytrends.com Wed, 29 Jun 2022 07
- Why AstraZeneca Is Buying Icosavax For $1.1 Billion - Investopedia ue, 12 Dec 2023 08
- Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company - GeekWire hu, 29 Jul 2021 07
- Developers’ RSV esprit draws Astrazeneca to $1.1B Icosavax buyout - bioworld.com ue, 12 Dec 2023 08
- ‘With Risk Comes Opportunity’: Oppenheimer Suggests 2 Stocks to Buy, Including One With 170% Upside Potential - Yahoo Finance hu, 26 Jan 2023 08
- Why Is Harbor Custom Development (HCDI) Stock Down 34% Today? - InvestorPlace ue, 12 Dec 2023 08
- Oracle's Falling, but You Won't Want to Miss This Soaring Biotech Stock - The Motley Fool ue, 12 Dec 2023 08
- Icosavax stock tanks after announcing disappointing interim SARS-CoV-2 Phase 1/2 results - drugdiscoverytrends.com Fri, 25 Mar 2022 07
- Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca - GlobeNewswire ue, 12 Dec 2023 08
- Why Is Achieve Life Sciences (ACHV) Stock Down 44% Today? - InvestorPlace ue, 12 Dec 2023 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ICVX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|